FI962993A - Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia - Google Patents

Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia Download PDF

Info

Publication number
FI962993A
FI962993A FI962993A FI962993A FI962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A
Authority
FI
Finland
Prior art keywords
ethanoestra
14alpha
17alpha
17beta
triene
Prior art date
Application number
FI962993A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962993A0 (fi
Inventor
Clemens Guenther
Ralph Lipp
Ulrich Taeuber
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI962993A publication Critical patent/FI962993A/fi
Publication of FI962993A0 publication Critical patent/FI962993A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI962993A 1994-01-27 1996-07-26 Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia FI962993A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (de) 1994-01-27 1994-01-27 MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL

Publications (2)

Publication Number Publication Date
FI962993A true FI962993A (fi) 1996-07-26
FI962993A0 FI962993A0 (fi) 1996-07-26

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962993A FI962993A0 (fi) 1994-01-27 1996-07-26 Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia

Country Status (6)

Country Link
EP (1) EP0741572A1 (ja)
JP (1) JPH09510697A (ja)
AU (1) AU5971294A (ja)
FI (1) FI962993A0 (ja)
NO (1) NO963128D0 (ja)
WO (1) WO1995020392A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (ja) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0370220B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen Applikation enthaltend Gestoden
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
NO963128L (no) 1996-07-26
NO963128D0 (no) 1996-07-26
JPH09510697A (ja) 1997-10-28
WO1995020392A1 (de) 1995-08-03
AU5971294A (en) 1995-08-15
EP0741572A1 (de) 1996-11-13
FI962993A0 (fi) 1996-07-26

Similar Documents

Publication Publication Date Title
BR9508707A (pt) Dispositivo estabilizador
EP0683401A3 (en) Locating device.
MA24062A1 (fr) Heteroatome comprenant des cyclopentano-pyridile oxazolidinones
GB2298498B (en) Blade holding device
DE59503468D1 (de) Stempelgerät
DE59600062D1 (de) Mischvorrichtung
DE59607626D1 (de) Mischvorrichtung
NO305341B1 (no) Anordning for elektro-fisking
DE69521774D1 (de) Funktelefongerät
NL1001892A1 (nl) Verpakkingsinrichting.
DE9412827U1 (de) Offenhaltevorrichtung
DE9408846U1 (de) Tragvorrichtung
DE69612672D1 (de) Mischvorrichtung
FI962993A (fi) Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia
DE29512328U1 (de) Tragvorrichtung
DE69523697T2 (de) Belüftungsvorrichtung
DE9402500U1 (de) Signaturvorrichtung
DE69508843D1 (de) Verpackungsvorrichtung
DE9411539U1 (de) Tragvorrichtung
NO950149D0 (no) Komposteringsanordning
KR960002976U (ko) 조작장치
DE29501512U1 (de) Mischvorrichtung
DE9415775U1 (de) Begasungsvorrichtung
GB9426108D0 (en) Stabilising device
DE59503463D1 (de) Stempelgerät

Legal Events

Date Code Title Description
FD Application lapsed